UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   Form 10-QSB


(Mark one)

[X]  Quarterly  Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the quarterly period ended June 30, 2006

[_]  Transition Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the transition period from ______________ to _____________


Commission File Number: 0-32379


                            American Ammunition, Inc.
--------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)


         Nevada                                              91-2021594
------------------------                             --------------------------
(State of incorporation)                               (IRS Employer ID Number)


                      3545 NW 71st Street, Miami, FL 33147
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (305) 835-7400
--------------------------------------------------------------------------------
                           (Issuer's telephone number)




Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. YES [X] NO [_]


Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act): YES [_] NO [X]


State the number of shares outstanding of each of the issuer's classes of common
equity as of the latest practicable date: August 16, 2006: 5,600,309


Transitional Small Business Disclosure Format (check one): YES [_] NO [X]







                            American Ammunition, Inc.

                 Form 10-QSB for the Quarter ended June 30, 2006

                                Table of Contents


                                                                          Page
Part I - Financial Information

  Item 1   Financial Statements                                             3

  Item 2   Management's Discussion and Analysis or Plan of Operation       21

  Item 3   Controls and Procedures                                         24


Part II - Other Information

  Item 1   Legal Proceedings                                               25

  Item 2   Recent Sales of Unregistered Securities and Use of Proceeds     25

  Item 3   Defaults Upon Senior Securities                                 27

  Item 4   Submission of Matters to a Vote of Security Holders             27

  Item 5   Other Information                                               27

  Item 6   Exhibits                                                        27


Signatures                                                                 27



















                                     Part I

Item 1 - Financial Statements



                   American Ammunition, Inc. and Subsidiaries
                           Consolidated Balance Sheets
                             June 30, 2006 and 2005
                                   (Unaudited)

                                                                                June 30, 2006   June 30, 2005
                                                                                -------------   -------------
                                                                                            
         ASSETS
Current Assets
   Cash on hand and in bank                                                     $    250,413      $    486,609
   Accounts receivable - trade, net of
     allowance for doubtful accounts of $10,000 and $-0-, respectively               241,954           192,855
   Inventory                                                                         426,676           548,616
   Prepaid expenses                                                                   55,324            56,382
                                                                                ------------      ------------
     Total Current Assets                                                            974,367         1,284,462
                                                                                ------------      ------------
Property and Equipment - at cost                                                           -         3,142,838
                                                                                ------------      ------------
Other Assets                                                                         294,424           322,591
                                                                                ------------      ------------
TOTAL ASSETS                                                                    $  1,268,791      $  4,749,891
                                                                                ============      ============
         LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
   Notes payable to shareholders                                                $  1,075,000      $    150,000
   Working capital advance                                                           150,000                 -
   Customer deposits                                                                 188,020           440,906
   Accounts payable - trade                                                          829,847           736,255
   Accrued salaries and wages                                                        337,648           173,492
   Accrued interest payable                                                           30,162            15,000
   Accrued dividends payable                                                          65,084            33,949
                                                                                ------------      ------------
     Total Current Liabilities                                                     2,675,761         1,549,602
                                                                                ------------      ------------
Commitments and Contingencies

Convertible Debenture                                                                226,365           241,365
                                                                                ------------      ------------
Stockholders' Equity (Deficit)
   Preferred stock - $0.001 par value
     20,000,000 shares authorized.
       2,022,902 and 2,009,582 shares and outstanding, respectively                    2,022             2,010
   Common stock - $0.001 par value.
     300,000,000 shares authorized.
     5,122,931 and 3,795,365 shares issued and outstanding                             5,123             3,795
   Additional paid-in capital                                                     25,814,532        25,018,438
   Accumulated deficit                                                           (27,280,012)      (22,026,926)
                                                                                ------------      ------------
                                                                                  (1,458,335)        2,997,317
   Stock subscription receivable                                                    (175,000)          (38,393)
                                                                                ------------      ------------
     Total Stockholders' Equity (Deficit)                                         (1,633,335)        2,958,924
                                                                                ------------      ------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                      $  1,268,791      $  4,749,891
                                                                                ============      ============


   The financial information presented herein has been prepared by management
           without audit by independent certified public accountants.

                   The accompanying notes are an integral part
                  of these consolidated financial statements.

                                        3





                   American Ammunition, Inc. and Subsidiaries
      Consolidated Statements of Operations and Comprehensive Income (Loss)
                Six and Three months ended June 30, 2006 and 2005
                                   (Unaudited)

                                              Six months        Six months       Three months   Three months
                                                 ended             ended            ended          ended
                                             June 30, 2006      June 30, 2005   June 30, 2006   June 30, 2005
                                             -------------      -------------   -------------   -------------
                                                                                    

Revenues                                     $   1,305,296      $   1,855,010   $     622,435   $     684,693
                                             -------------      -------------   -------------   -------------
Cost of Sales
   Materials, Direct Labor
      and other direct costs                     1,737,969          2,502,842         643,138       1,153,511
   Depreciation                                     31,024            382,311               -         195,062
                                             -------------      -------------   -------------   -------------
      Total Cost of Sales                        1,768,993          2,885,153         643,138       1,348,573
                                             -------------      -------------   -------------   -------------
Gross Profit                                      (463,697)        (1,030,143)        (20,703)       (676,300)
                                             -------------      -------------   -------------   -------------
Operating Expenses
   Research and development expenses                     -              1,611               -           6,474
   Selling and marketing expenses                   74,075            111,752          18,258         130,875
   Other operating expenses                        663,017            631,521         338,109         304,425
   Interest expense                                 76,621             10,131          39,376             507
   Depreciation and amortization                    27,569             30,203          13,784           1,893
   Compensation expense related to
      common stock issuances at less
      than "fair value"                            139,373            200,502         139,373          35,000
                                             -------------      -------------   -------------   -------------
      Total Operating Expenses                     980,655            985,920         548,900         479,174
                                             -------------      -------------   -------------   -------------

Loss from Operations                            (1,444,352)        (2,016,063)       (569,603)     (1,155,474)

Other Income (Expense)
   Interest and other income                       189,492              6,232         147,935             167
                                             -------------      -------------   -------------   -------------
Income (Loss) before Income Taxes               (1,254,860)        (2,009,831)       (421,668)     (1,155,307)

Provision for Income Taxes                               -                  -               -               -
                                             -------------      -------------   -------------   -------------

Net Income (Loss)                               (1,254,860)        (2,009,831)       (421,668)     (1,155,307)
Other Comprehensive Income                               -                  -               -               -
                                             -------------      -------------   -------------   -------------

Comprehensive Income (Loss)                  $  (1,254,860)     $  (2,009,831)  $    (421,668)  $  (1,155,307)
                                             =============      =============   =============   =============

Loss per weighted-average share of
   common stock outstanding,
   computed on net loss -
   basic and fully diluted                   $       (0.28)     $       (0.58)  $       (0.09)  $       (0.32)
                                             =============      =============   =============   =============
Weighted-average number of
   common shares outstanding                     4,537,640          3,472,930       4,797,286       3,557,402
                                             =============      =============   =============   =============


   The financial information presented herein has been prepared by management
           without audit by independent certified public accountants.

                   The accompanying notes are an integral part
                  of these consolidated financial statements.

                                        4





                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                     Six months ended June 30, 2006 and 2005
                                   (Unaudited)

                                                                                 Six months      Six months
                                                                                    ended           ended
                                                                                June 30, 2006   June 30, 2005
                                                                                -------------   -------------
                                                                                          
Cash flows from operating activities
   Net loss for the year                                                        $  (1,254,860)  $  (2,009,831)
   Adjustments to reconcile net loss to
     net cash provided by operating activities
       Depreciation and amortization                                                   85,563         412,514
       Bad debt expense                                                                14,153               -
       Operating expenses paid with common stock                                       20,186
       Compensation expense related to common stock
         issuances at less than "fair value"                                          139,373         200,502
       (Increase) Decrease in
         Accounts receivable                                                          315,320         446,589
         Inventory                                                                    133,414         363,808
         Prepaid expenses, deposits and other                                           1,465          (2,464)
       Increase (Decrease) in
         Accounts payable - trade                                                     (41,770)       (250,630)
         Other accrued expenses                                                        91,719
         Accrued interest payable                                                      40,494
         Customer deposits                                                            (44,670)
                                                                                -------------   -------------
Net cash used in operating activities                                                (499,613)       (797,062)
                                                                                -------------   -------------
Cash flows from investing activities
   Purchase of property and equipment                                                 (31,024)        (98,400)
                                                                                -------------   -------------
Net cash used in investing activities                                                 (31,024)        (98,400)
                                                                                -------------   -------------
Cash flows from financing activities
   Cash advanced on loans from shareholders                                           100,000         150,000
   Cash paid to obtain capital                                                              -         (10,000)
   Cash received on sale of preferred stock                                           250,000               -
   Cash received on sale of common stock                                                    -         436,606
                                                                                -------------   -------------
Net cash provided by financing activities                                             350,000         576,606
                                                                                -------------   -------------
Increase (Decrease) in Cash                                                          (180,637)       (318,856)
Cash at beginning of year                                                             431,050         805,465
                                                                                -------------   -------------
Cash at end of period                                                           $     250,413   $     486,609
                                                                                =============   =============
Supplemental disclosure of interest and income taxes paid
     Interest paid for the period                                               $       9,157   $      10,131
                                                                                =============   =============
     Income taxes paid for the period                                           $           -   $           -
                                                                                =============   =============
Supplemental disclosure of non-cash investing and financing activities
     Conversion of debt and/or accrued interest payable
       into common stock                                                        $     36,720    $      25,000
                                                                                =============   =============
     Common stock issued in payment for costs of raising capital                $           -   $           -
                                                                                =============   =============
     Common stock issued in payment of accrued dividends
       on Preferred Stock - Series A and Series B                               $           -   $       9,171
                                                                                =============   =============


   The financial information presented herein has been prepared by management
           without audit by independent certified public accountants.

                   The accompanying notes are an integral part
                  of these consolidated financial statements.

                                        5




                   American Ammunition, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


Note A - Organization and Description of Business

American Ammunition,  Inc. (AAI or Company) was incorporated on February 1, 2000
in accordance with the Laws of the State of California. The Company functions as
a holding company providing  management  oversight services to it's wholly-owned
operating  subsidiaries;  F&F Equipment,  Inc. and Industrial Plating Enterprise
Co.

F&F Equipment,  Inc.(F&F) was incorporated on October 4, 1983 in accordance with
the Laws of the State of Florida. F&F is engaged in the design,  manufacture and
international  sales of small arms  ammunition.  F&F has  conducted its business
operations under the assumed name of "American Ammunition" since its inception.

Industrial  Plating  Enterprise Co. (IPE),  which was incorporated and commenced
production on June 14, 2002.  IPE is a fully  licensed and approved state of the
art electrochemical  metallization facility for processing the Company's line of
small arms  projectiles as well as other  products and services while  employing
environmentally  sound water conservation and proven waste treatment techniques.
The facility meets or exceeds all current environmental  requirements and enjoys
the "conditionally exempt small quantity generator" status for State and Federal
regulations.  All  activities of IPE since it's inception have been dedicated to
the needs and demands of F&F.

On January 9, 2006,  by written  consent in lieu of  meeting,  a majority of the
Company's  stockholders  approved a  recommendation  by the  Company's  Board of
Directors  to effect a one share for twenty  shares  reverse  stock split of our
common stock,  par value $.001 per share,  with fractional  shares rounded up to
the nearest whole share.  The reverse split became  effective on that date. As a
result of the reverse split,  the total number of issued and outstanding  shares
of the Company's  common stock  decreased  from  92,576,839 to  4,629,381shares,
after giving effect to rounding for fractional shares. The effect of this action
is reflected in the  Company's  financial  statements as of the first day of the
first period presented.


Note B - Preparation of Financial Statements

The  Company and its  subsidiaries  follow the accrual  basis of  accounting  in
accordance with accounting principles generally accepted in the United States of
America and have adopted a year-end of December 31 for all entities.

The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period. Actual results could differ from those estimates.

Management further acknowledges that it is solely responsible for adopting sound
accounting  practices,   establishing  and  maintaining  a  system  of  internal
accounting  control and preventing and detecting  fraud. The Company's system of
internal  accounting  control is designed to assure,  among other items, that 1)
recorded  transactions  are valid; 2) valid  transactions  are recorded;  and 3)
transactions  are  recorded in the proper  period in a timely  manner to produce
financial  statements which present fairly the financial  condition,  results of
operations  and cash  flows of the  Company  for the  respective  periods  being
presented

During interim periods, the Company follows the accounting policies set forth in
its annual  audited  financial  statements  filed with the U. S.  Securities and
Exchange  Commission  on its  Annual  Report on Form  10-KSB  for the year ended
December 31, 2005.  The  information  presented  within these interim  financial
statements  may not  include all  disclosures  required  by  generally  accepted
accounting  principles  and the  users of  financial  information  provided  for
interim periods should refer to the annual  financial  information and footnotes
when reviewing the interim financial results presented herein.

                                        6




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note B - Preparation of Financial Statements - Continued

In the opinion of management,  the accompanying  interim  financial  statements,
prepared in  accordance  with the U. S.  Securities  and  Exchange  Commission's
instructions   for  Form  10-QSB,   are   unaudited  and  contain  all  material
adjustments,  consisting  only of  normal  recurring  adjustments  necessary  to
present fairly the financial condition,  results of operations and cash flows of
the Company for the respective  interim  periods  presented.  The current period
results of operations are not necessarily indicative of results which ultimately
will be reported for the full fiscal year ending December 31, 2006.

For  segment  reporting  purposes,  the Company  operated  in only one  industry
segment during the periods represented in the accompanying  financial statements
and makes all  operating  decisions and  allocates  resources  based on the best
benefit to the Company as a whole.

The  accompanying  consolidated  financial  statements  contain the  accounts of
American Ammunition, Inc. and its wholly-owned subsidiaries, F&F Equipment, Inc.
and Industrial Plating Enterprise Co. All significant intercompany  transactions
have been eliminated.  The consolidated entities are collectively referred to as
"Company".


Note C - Summary of Significant Accounting Policies

1.   Cash and cash equivalents

     For  Statement of Cash Flows  purposes,  the Company  considers all cash on
     hand  and  in  banks,  certificates  of  deposit  and  other  highly-liquid
     investments with maturities of three months or less, when purchased,  to be
     cash and cash equivalents.

     Cash  overdraft  positions may occur from time to time due to the timing of
     making bank deposits and releasing checks, in accordance with the Company's
     cash management policies.

(2)  Accounts receivable and Revenue Recognition

     In the normal course of business,  the Company extends  unsecured credit to
     virtually  all of its  customers  which are located  throughout  the United
     States.  Because of the credit risk  involved,  management  has provided an
     allowance for doubtful accounts which reflects its opinion of amounts which
     will   eventually   become   uncollectible.   In  the  event  of   complete
     non-performance, the maximum exposure to the Company is the recorded amount
     of trade  accounts  receivable  shown on the  balance  sheet at the date of
     non-performance.

     The Company ships all product on an FOB-Plant,  "as-is" basis. Accordingly,
     revenue  is  recognized  by the  Company  at the point at which an order is
     shipped at a fixed price,  collection is reasonably assured and the Company
     has no remaining  performance  obligations related to the sale. The Company
     sells all  products  with "no right of  return"  by the  purchaser  for any
     factor other than defects in the product's production.

     In limited situations, the Company may elect to accept product returns from
     customers on a  case-by-case  basis to offset unpaid  accounts  receivable.
     These  situations  are a "last case"  scenario and are  initiated by senior
     management through negotiations with the respective customer.

3.   Inventory

     Inventory  consists of raw  materials,  work-in-process  and finished goods
     related to the production and sale of small arms  ammunition.  Inventory is
     valued at the lower of cost or market using the first-in, first-out method.


                                        7




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note C - Summary of Significant Accounting Policies - Continued

4.   Property, plant and equipment

     Property and  equipment are recorded at  historical  cost.  These costs are
     depreciated over the estimated useful lives of the individual  assets using
     the straight-line method, generally three to ten years.

     Gains and losses from  disposition of property and equipment are recognized
     as incurred and are included in operations.

     In accordance  with  Statement of Financial  Accounting  Standards No. 144,
     "Accounting  for the  Impairment  or Disposal of  Long-Lived  Assets",  the
     Company  follows the policy of evaluating  all property and equipment as of
     the end of each reporting  quarter.  At December 31, 2005,  pursuant to the
     requirements of this accounting standard, management recorded an impairment
     against  the  future   recoverability  of  these  assets  of  approximately
     $2,777,829.


5.   Income Taxes

     The Company uses the asset and liability  method of  accounting  for income
     taxes.  At June 30, 2006 and 2005,  the deferred tax asset and deferred tax
     liability accounts,  as recorded when material to the financial statements,
     are  entirely the result of temporary  differences.  Temporary  differences
     represent  differences in the recognition of assets and liabilities for tax
     and financial reporting purposes,  primarily  accumulated  depreciation and
     amortization, allowance for doubtful accounts and vacation accruals.

     As of June 30, 2006 and 2005, respectively,  the deferred tax asset related
     to the Company's net operating loss carryforward is fully reserved.  In the
     event that these carryforwards were not fully utilized, these carryforwards
     began to expire in 2005.


6.   Earnings (loss) per share

     Basic  earnings  (loss) per share is computed  by  dividing  the net income
     (loss) available to common shareholders by the  weighted-average  number of
     common shares  outstanding  during the respective  period  presented in our
     accompanying financial statements.

     Fully diluted earnings (loss) per share is computed similar to basic income
     (loss) per share  except that the  denominator  is increased to include the
     number of common  stock  equivalents  (primarily  outstanding  options  and
     warrants).

     Common  stock  equivalents  represent  the  dilutive  effect of the assumed
     exercise of the outstanding stock options and warrants,  using the treasury
     stock method, at either the beginning of the respective period presented or
     the date of  issuance,  whichever  is later,  and only if the common  stock
     equivalents  are  considered  dilutive  based upon the Company's net income
     (loss) position at the calculation date.

     As of June 30, 2006 and 2005,  and subsequent  thereto,  the Company had no
     options  outstanding.  The outstanding  warrants and convertible  preferred
     stock and mandatorily  convertible  debentures are anti-dilutive due to the
     Company's net operating loss position.


7.   Advertising costs

     The Company does not conduct any direct  response  advertising  activities.
     For non-direct response advertising, the Company charges the costs of these
     efforts  to  operations  at the  first  time  the  related  advertising  is
     published.


                                        8




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note D - Fair Value of Financial Instruments

The carrying amount of cash,  accounts  receivable,  accounts  payable and notes
payable, as applicable,  approximates fair value due to the short term nature of
these items  and/or the current  interest  rates  payable in relation to current
market conditions.

Interest  rate risk is the risk  that the  Company's  earnings  are  subject  to
fluctuations  in interest  rates on either  investments  or on debt and is fully
dependent  upon  the  volatility  of  these  rates.  The  Company  does  not use
derivative instruments to moderate its exposure to interest rate risk, if any.

Financial  risk  is  the  risk  that  the  Company's  earnings  are  subject  to
fluctuations in interest rates or foreign exchange rates and are fully dependent
upon the  volatility  of  these  rates.  The  company  does  not use  derivative
instruments to moderate its exposure to financial risk, if any.


Note E - Inventory

As of June 30, 2006 and 2005,  inventory,  as valued using the  lower-of-cost or
market, consisted of the following components:

                                          June 30,          June 30,
                                            2006             2005
                                        -----------------------------
         Raw materials                  $  398,511         $  339,605
         Work in process                    19,313            125,533
         Finished goods                      8,852             83,478
                                        ----------         ----------
         Totals                         $  426,676         $  548,616
                                        ==========         ==========


Note F - Property and Equipment

Property and equipment consist of the following components:

                                     June 30,         June 30,       Estimated
                                       2006             2005         useful life
                                    ------------- ------------------------------

   Manufacturing equipment          $   7,939,335    $ 8,083,624     3-10 years
   Office furniture and fixtures           69,889         55,577     3- 7 years
   Leasehold improvements                 190,277        190,277     8-20 years
                                    -------------    -----------
                                        8,199,501      8,329,478
   Accumulated depreciation            (5,575,782)    (5,186,640)
   Impairment of recoverability
         of carrying value             (2,623,719)             -
                                    -------------   ------------
   Net property and equipment       $           -   $  3,142,838
                                    =============   ============

Total depreciation expense charged to operations for the six month periods ended
June 30, 2006 and 2005, respectively, was approximately $31,024 and $409,880.

In  accordance  with  Statement  of  Financial  Accounting  Standards  No.  144,
"Accounting  for the Impairment or Disposal of Long-Lived  Assets",  the Company
follows the policy of  evaluating  all property  and  equipment as of the end of
each reporting  quarter.  At December 31, 2005,  pursuant to the requirements of
this  accounting  standard,  management  recorded an  impairment  for the future
recoverability of these assets of approximately $2,777,829.



                                        9




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note G - Convertible Debenture

The Company  entered into a  Securities  Purchase  Agreement  with La Jolla Cove
Investors,  Inc. ("La Jolla") on October 4, 2002 for the sale of (I) $250,000 in
convertible  debentures and (ii) warrants to buy 30,000,000 shares of our common
stock.  On March 13, 2003 and May 6, 2003,  La Jolla  advanced an  aggregate  of
$350,000 to our company which such funding was  allocated  towards the principal
balance of our convertible debentures.

As of June 30, 2006, the  outstanding  balance on the  convertible  debenture is
approximately $226,365 and we have approximately 2,263,650 warrants outstanding.
A recap of the debenture activity is as follows:

                                            DebentureWarrant
                                          (in dollars) (in shares)
                                          -------------------------

       Initial amount                     $  600,000      6,000,000
       2003 redemptions                     (208,635)    (2,086,350)
       2004 redemptions                     (125,000)    (1,250,000)
       2005 redemptions                      (40,000)      (400,000)
                                          ----------     ----------

       Balances outstanding
         at June 30, 2006                 $  226,365      2,263,650
                                          ==========     ==========

The  debentures  bear  interest at 8%,  mature on June 31 [sic],  2007,  and are
convertible  into the  Company's  common  stock,  at the  selling  stockholder's
option.  The  convertible  debentures  are  convertible  into the  number of the
Company's shares of common stock equal to the principal amount of the debentures
being  converted  multiplied  by 11,  less the product of the  conversion  price
multiplied by 10 times the dollar amount of the debenture.  The conversion price
for the  convertible  debentures  is the lesser of (I) $1.00 or (ii) seventy six
percent of the average of the five lowest volume weighted  average prices during
the twenty (20) trading days prior to the conversion.  Accordingly,  there is in
fact no limit on the number of shares into which the debenture may be converted.
However,  in the event that our market  price is less than $0.30 per share,  the
Company  will have the option to prepay the  debenture  at 125% rather than have
the debenture  converted.  In addition,  the selling stockholder is obligated to
exercise the warrant  concurrently with the submission of a conversion notice by
the selling  stockholder.  As of June 30, 2006, the warrant is exercisable  into
2,263,650 shares of common stock at an exercise price of $1.00 per share.

In December 2004, we entered into an addendum to the convertible debenture and
warrant whereby the Company agreed to the following:

     *    the discount multiplier was reduced from eighty percent to seventy six
          percent;

     *    within five  business  days after this  registration  statement  being
          declared  effective,  La  Jolla is  required  to  submit  a  debenture
          conversion  in the  amount of  $10,000  and every  ten  business  days
          thereafter La Jolla shall submit three additional debenture conversion
          in the amount of $10,000 each;

     *    within five  business  days after this  registration  statement  being
          declared effective, La Jolla shall wire $400,000 to us as a prepayment
          towards the exercise of its warrant; and

     *    immediately  following  the  sale of all  shares  held by La  Jolla in
          connection with the debenture  conversions in the aggregate  amount of
          $40,000,  La Jolla shall wire  $275,000 to us as a prepayment  towards
          the exercise of its warrant and shall submit a debenture conversion in
          the amount of $6,250 on the first business day of each month until the
          debenture is no longer outstanding.




                                       10




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note G - Convertible Debenture - continued

In May 2005, we entered into an additional addendum to the convertible debenture
and warrant whereby the Company agreed to the following:

     *    The Company shall deposit 4,000,000 unregistered shares in the name of
          LaJolla with the  Company's  Escrow Agent and,  upon  confirmation  of
          receipt,  LaJolla will wire the Company  $150,000 as an advance on the
          $400,000  amount that LaJolla was  obligated  to fund  pursuant to the
          December 2004 Addendum.  In the event that the Company's  Registration
          Statement  was not  declared  effective  within nine (9) months of the
          date of this Addendum, the 4,000,000 shares in escrow will be released
          to LaJolla and sold by LaJolla  pursuant to Rule 144. If LaJolla sells
          these  shares for net sales  proceeds of more than  $150,000  (without
          interest  accruing on this  amount),  the excess over $150,000 will be
          refunded to the Company.
     *    The  maturity  date  of the  convertible  debenture  and  warrant  was
          extended to June 31,  [sic],  2007.  * All other terms and  conditions
          remain in full force and effect.

LaJolla has contractually  agreed to restrict its ability to convert or exercise
its  warrants  and  receive  shares of our common  stock such that the number of
shares of common stock held by them and their  affiliates  after such conversion
or exercise does exceed 4.9% of the then issued and outstanding shares of common
stock.

Due to the  contractually  agreed  mandatory  conversion of this Debenture,  the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

As the warrant is  non-detachable  from the Debenture and requires  simultaneous
exercise upon  conversion of the Debenture,  no value was assigned to the issued
warrant.  Upon exercise of the warrant,  the Company will record the issuance of
the  underlying  shares as a new  issuance  of common  stock on the date of each
respective exercise.

On various dates through  December 31, 2003,  the  Debenture  Holder  elected to
convert an aggregate $208,635, through 24 separate transactions,  in outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 4,561,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 2,086,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $2,086,350.

On various  dates between  January 1, 2004 and December 31, 2004,  the Debenture
Holder   elected  to  convert  an   aggregate   $125,000,   through  6  separate
transactions,  in outstanding  Debenture principal into registered common stock.
This election  caused the Company to issue  4,150,000  shares of common stock to
the  Debenture  Holder.  Additionally,  pursuant  to  the  contract  terms,  the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase  1,250,000  shares of the Company's  common stock for gross proceeds of
$1,250,000.  As of December  31, 2004,  an aggregate of 1,000,000  shares of the
Company's  common  stock have been  issued by the  Company and are being held in
escrow by the Company's  counsel  pending receipt of the final $175,000 from the
Debenture Holder. As of June 30, 2006, this amount remains unpaid.

On various dates between June 28, 2005 and August 10, 2005, the Debenture Holder
elected to convert an aggregate  $40,000,  through 4 separate  transactions,  in
outstanding  Debenture  principal into  registered  common stock.  This election
caused the Company to issue  5,872,048  shares of common stock to the  Debenture
Holder.  Additionally,  pursuant to the contract  terms,  the  Debenture  Holder
concurrently  exercised a portion of the outstanding Warrant to purchase 400,000
shares of the Company's common stock for gross proceeds of $400,000.




                                       11




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note H - Preferred Stock Transactions

Preferred  stock  consists  of the  following  as of June  30,  2006  and  2005,
respectively:



                                                       June 30, 2006       June 30, 2005
                                                     -----------------    ---------------
                                                     # shares   value     # shares   value
                                                     -------- --------    -------- --------
                                                                       
Series A Cumulative Convertible Preferred Stock        12,000 $ 60,000      12,000 $ 60,000
Series B Cumulative Convertible Preferred Stock        55,020  275,100      91,700  458,500
Series C Convertible Preferred Stock                1,905,882  324,000   1,905,882  324,000
Series E 8% Convertible Preferred Stock                50,000  250,000           -        -
                                                    --------- --------   --------- --------

                                                    2,022,902 $909,100   2,009,582 $842,500
                                                    ========= ========   ========= ========


Series A Convertible Preferred Stock

In September,  October and November 2001, the Company sold an aggregate  222,600
shares of $5.00 Series A Convertible  Preferred Stock (Series A Preferred Stock)
for total  proceeds  of  approximately  $1,113,000  through a Private  Placement
Memorandum.  The Series A Convertible  Preferred  Stock  provides for cumulative
dividends at a rate of 8.0% per year,  payable  quarterly,  in cash or shares of
the  Company's  common stock at the Company's  election.  Each share of Series A
Preferred  Stock is  convertible  into 11 shares of the  Company's  common stock
initially  at any time  after 6 months  of the  date of issue  and  prior to the
notice of redemption  at the option of the holder,  subject to  adjustments  for
customary  anti-dilution events. In December 2001, at the request of the holders
of the Series A Preferred Stock, the Company and the individual holders modified
the holding period for conversion to allow for conversion in December 2001.

In September 2001, the Company's principal stockholder  converted  approximately
$4,007,327 of unsecured  debt and  approximately  $3,546,273  of cumulative  and
unpaid accrued interest into 1,510,710 shares of Series A Preferred Stock.

In  September  2001, a creditor of the Company  agreed to convert  approximately
$10,000 of trade accounts payable into 2,000 shares of Series A Preferred Stock.

In December 2001,  concurrent with a modification in the holding period prior to
conversion,  certain holders of the Series A Preferred Stock orally notified the
Company of their intent to exercise the conversion  features on 1,749,720 issued
and outstanding  shares of Series A Preferred  Stock into  19,246,920  shares of
common  stock prior to December  31,  2001.  Due to the timing of the  requisite
documentation,  the  clerical  activities  related to this  conversion  were not
completed until February 2002.

In conjunction with the Series A Preferred Stock, certain shares were sold after
the Company's common stock was approved for trading by the National  Association
of Securities  Dealers on the OTC Bulletin  Board in October 2001. The shares of
Series A Preferred  Stock sold  subsequent  to this date had an  equivalent  per
share  value of  common  stock  below  the  ending  quoted  market  price of the
Company's common stock on their respective issue dates. This difference  created
a Beneficial  Conversion  Feature  Discount of  approximately  $1,207,993.  This
discount was then  amortized  over the unexpired time period between the date of
issue of the eligible shares and the eligible  conversion date, as amended.  All
of the shares sold  subsequent  to the initial  trading  date were  converted in
December  2001  and,  accordingly,  the  approximate  $1,207,993  in  Beneficial
Conversion Feature Discount was fully amortized to operations.

In December 2002, a holder of 5,000 shares of Series A Preferred Stock exercised
his  conversion  rights and converted  these shares of Series A Preferred  Stock
into 55,000 shares of restricted, unregistered common stock.

In January 2003,  three  separate  holders of 9,000 shares of Series A Preferred
Stock exercised their  conversion  rights and converted these shares of Series A
Preferred stock into 99,000 shares of restricted, unregistered common stock.

                                       12




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note H - Preferred Stock Transactions - Continued

Series B Convertible Preferred Stock

In May 2003,  the Company  sold an  aggregate  91,700  shares of $5.00  Series B
Convertible  Preferred  Stock (Series B Preferred  Stock) for total  proceeds of
approximately  $458,500 through a separate  Private  Placement  Memorandum.  The
Series B Convertible Preferred Stock provides for cumulative dividends at a rate
of 8.0% per year, payable  quarterly,  in cash or shares of the Company's common
stock at the  Company's  election.  Each  share of Series B  Preferred  Stock is
convertible  into 11 shares of the Company's  common stock initially at any time
after 6 months of the date of issue and prior to the notice of redemption at the
option of the holder, subject to adjustments for customary anti-dilution events.

In  September  and  December  2004,  respectively,  the  Holders of the Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340 shares of Series B Preferred Stock for 66,810  post-reverse  split shares
of restricted, unregistered common stock.

On March 31 and  June  30,  2006,  respectively,  the  holders  of the  Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340  shares  (9,170 shares per  conversion)  of Series B Preferred  Stock for
415,706 shares of restricted, unregistered common stock.

Series C Convertible Preferred Stock

In November  2004,  the Company sold  1,905,882  shares of Series C  Convertible
Preferred  Stock to an  existing  shareholder  and  officer of the  Company in a
private  transaction  pursuant to Section (4)2 of the Securities Act of 1933 for
gross proceeds of approximately $324,000. No underwriter was used in conjunction
with this transaction.

The Series C  Convertible  Preferred  Stock  provides for dividends at a rate of
4.0% per annum,  to be declared  and paid monthly in either cash or stock at the
discretion of the Company.

Each share of Series C  Preferred  Stock is  convertible  at a rate of $0.18 per
share into  1,800,000  shares of the  Company's  common stock at any time at the
option of the  holder,  subject to  adjustments  for  customary  anti-  dilution
events.

Series E 8% Convertible Preferred Stock

On March 1, 2006, the Company issued a Private Placement  Memorandum offering up
to 200,000  shares of 8%  Convertible  Preferred  Stock at an offering  price of
$5.00 per share on a "best efforts" basis through an unrelated placement agent.

The Series E 8% Convertible Preferred Stock provides for cumulative dividends at
the rate of 8% per  year,  payable  quarterly,  50% in cash and 50% in shares or
100% in cash at the Company's  election.  In the event the Company elects to pay
such dividends in shares of the Company's  Common Stock, the number of shares to
be issued shall be based on the average of the closing  prices of the  Company's
Common Stock, as reported on the NASDAQ Over the Counter Bulletin Board (or such
other  market on which the  Company's  Common  Stock is then  traded) for the 10
consecutive trading days preceding the record date for each such dividend,  with
such record date being the 14th day preceding the end of each calendar quarter.




                                       13




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note H - Preferred Stock Transactions - Continued

Series E 8% Convertible Preferred Stock - continued

Each share of Series E Convertible  Preferred  Stock shall be  convertible  into
shares of the Company's Common Stock at any time after March 1, 2007. The number
of  shares to be issued  on a  conversion  shall be based on 80% of the  average
closing price of the Common Stock of the Company;  as reported on the NASDAQ OTC
Bulletin Board (or such other market on which such stock is traded) for ten (!0)
consecutive  trading days preceding the date the Company received notice of such
conversion.  Subject  to  certain  restrictions,  the  Series  E 8%  Convertible
Preferred Stock shall automatically  convert into shares of the Company's Common
Stock upon any of the  following  events:  (I) the sale by the Company of all or
substantially  all of  its  assets;  (ii)  the  consummation  of a  merger  or a
consolidation  in which the  Company is not the  survivor;  or (iii) the sale or
exchange of all or substantially all of the outstanding  shares of the Company's
common  stock  (including  by way of  merger,  consolidation,  or other  similar
action).

In the event of the liquidation,  dissolution or winding up of the Company,  the
holders  of  Series E  Convertible  Preferred  Stock  shall  have a  liquidation
preference  over  holders of common  stock and shares  junior to the Series E 8%
Convertible Preferred Stock equal to $5.50 per share. Additionally,  the Company
shall not impose or allow any additional  liens on it's existing fixed assets in
excess of  $1,000,000;  provided that at such time as total gross  proceeds from
the offering equal or exceed $2,000,000, the Company shall satisfy such existing
liens on its existing  fixed assets and shall not impose or allow any additional
liens on its existing  fixed assets unless  subordinated  to the interest of the
Series E 8%  Convertible  Preferred  Stock,  with such  preference  on the fixed
assets equal to the fixed asset value,  as  determined  in  accordance  with the
United States Generally Accepted Accounting  Principles ("GAAP"), of 150% of the
stated value of the aggregate of the outstanding  shares of Series E Convertible
Preferred  Stock  except for fixed  assets of the  Company  that were  otherwise
purchased pursuant to a security interest.

The Series E 8% Convertible  Preferred Stock shall be redeemable,  at the option
of the  Company,  for  cash in the  amount  of  $5.50  per  share  of  Series  E
Convertible  Preferred  Stock or for  shares of the  Company's  Common  Stock in
accordance with the Conversion  Rate, at any time after March 1, 2007, or in the
event the closing sale price of the Company's  Common Stock,  as reported on the
NASDAQ  Over the  Counter  Bulletin  Board  (or such  other  market on which the
Company's Common Stock is then traded),  is greater than or equal to $7.00 after
March 1, 2007 for any consecutive  five trading days. In addition,  the Series E
8% Convertible Preferred Stock shall be redeemable, at the option of the holder,
at any time for shares of the  Company's  Common  Stock in  accordance  with the
Conversion  Rate.  At any time after March 1, 2007, at the option of the holder,
the Series E 8% Convertible  Preferred Stock shall be redeemable for cash in the
amount of $5.10 per share of Series E Convertible  Preferred Stock or for shares
of the Company's Common Stock in accordance with the Conversion Rate. After such
date, if redemption is for cash,  shares will be redeemed at the rate of 1/10 of
such  aggregate  shares per  quarterly  period for any 10  consecutive  quarters
commencing  after  March 1, 2007.  Any  redemption  by either the Company or the
holder shall be subject to 15 days written notice.















                (Remainder of this page left blank intentionally)



                                       14




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note H - Preferred Stock Transactions - Continued

Series E 8% Convertible Preferred Stock - continued

The  Company  warrants  and  agrees  that if,  at any  time  within  the  period
commencing  on the date of the final closing of the Offering and expiring on the
5 th  anniversary  of the date thereof,  the Company  should file a registration
statement with the SEC under the Securities Act (other than in connection with a
merger or other  business  combination  transaction or pursuant to Form S-8), it
will give written  notice at least 30 calendar  days prior to the filing of each
such  registration  statement  to the  holders  of the  Series E 8%  Convertible
Preferred  Stock and the holders of the shares of the Common  Stock  issued upon
the  conversion or  redemption  of the shares of Series E Convertible  Preferred
Stock,  or their permitted  assigns  (Holders) of its intention to do so. If the
Holders  notify the Company  within 30 calendar  days after  receipt of any such
notice of its or their  desire to include any such shares of Common Stock issued
or issuable upon the  conversion  or  redemption of the Series E 8%  Convertible
Preferred Stock in such proposed registration  statement,  the Company shall use
its "best efforts" to have any such shares of Common Stock is issued or issuable
upon the conversion or redemption of the Series E 8% Convertible Preferred Stock
registered under such registration statement. Notwithstanding the foregoing, the
Company  shall  have the right at any time  after it shall  have  given  written
notice  (irrespective  of whether a written  request for  inclusion  of any such
securities  shall  have  been  made)  to elect  not to file  any  such  proposed
registration  statement,  or to withdraw  the same after the filing but prior to
the effective date thereof. If the managing  underwriter of an offering to which
the above  "piggyback  registration  rights" apply,  in good faith and for valid
business  reasons,  objects to such rights,  such objection  shall preclude such
inclusion. All expenses incurred by the Company in registration of the shares of
Common Stock issued or issuable upon the  conversion or redemption of The Series
E 8% Convertible Preferred Stock, including with out limitation all registration
and filing fees, listing fees, printing expenses,  fees and disbursements of all
independent  accounts, or counsel for the Company and the expense of any special
audits  incident  to or required by any such  registration  and the  expenses of
complying with the securities or blue sky laws of any jurisdiction shall be paid
by the Company.

The Company has agreed to pay the Placement Agent a cash commission equal to 10%
of the aggregate Purchase Price of the shares of Series E Convertible  Preferred
Stock sold by the Placement  Agent in the Offering  (Placement  Agent Fee).  The
Company shall also pay the Placement Agent reasonable  expenses  associated with
the Offering,  which expenses shall not exceed $50,000 (Expense  Allowance).  In
addition,  the Company shall issue to the Placement  Agent 500 warrants for each
$50,000 of Series E Convertible  Preferred  Stock sold by the Placement Agent in
the Offering  (Placement Agent Warrants),  each warrant  entitling the holder to
purchase 1 share of the Company's Common Stock at an exercise price of $0.90 per
share exercisable at any time for a period of 3 years from date of issuance.

Upon completion of the Maximum  Offering,  the Company will receive net proceeds
of  approximately  $900,000.00.  The Company intends to use the net proceeds for
potential  acquisitions,   working  capital,   general  corporate  purposes  and
repayment of outstanding debt.

The  Company  and the  Placement  Agent shall have  discretion  to increase  the
Maximum Offering to $2,000,000.00, without notice to investors..

As of June 30, 2006, the Company has sold 50,000 shares in a single  transaction
under  this  Private  Placement  Memorandum  and has  received  the gross  sales
proceeds of $250,000  and has accrued a payable to the  Placement  Agent for the
10% (or $25,000) fee due on this transaction.



                                       15




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note I - Common Stock Transactions

On January 9, 2006,  by written  consent in lieu of  meeting,  a majority of the
Company's  stockholders  approved a  recommendation  by the  Company's  Board of
Directors to effect a one share for twenty shares (1 for 20) reverse stock split
of our common stock, par value $.001 per share,  with fractional  shares rounded
up to the nearest whole share.  The reverse split became effective on that date.
As a result of the reverse  split,  the total  number of issued and  outstanding
shares  of  the   Company's   common  stock   decreased   from   92,576,839   to
4,629,381shares,  after giving  effect to rounding for  fractional  shares.  The
effect of this action is reflected in the Company's  financial  statements as of
the first day of the first period presented.

In  conjunction  with  the  above  discussed  reverse  stock  split,  all  share
references in the following paragraphs reflect the January 9, 2006 reverse split
action.

Calendar 2005 Transactions

On various dates between June 28, 2005 and August 10, 2005, the Debenture Holder
elected to convert an aggregate  $40,000,  through 4 separate  transactions,  in
outstanding  Debenture  principal into  registered  common stock.  This election
caused the  Company to issue  293,602  shares of common  stock to the  Debenture
Holder.  Additionally,  pursuant to the contract  terms,  the  Debenture  Holder
concurrently  exercised a portion of the outstanding Warrant to purchase 400,000
shares of the Company's common stock for gross proceeds of $400,000.

In  September  and  December  2004,  respectively,  the  Holders of the Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340  shares of Series B  Preferred  Stock for  66,810  shares of  restricted,
unregistered common stock.

Jn July 2005, the Company  issued  approximately  8,333 shares of  unregistered,
restricted  common  stock to Paul  Goebel,  the  Company's  Director of Domestic
Sales, as an employee bonus. These shares were valued at approximately  $17,166,
which  approximated the market value of the shares on the transaction  date. The
Company relied upon Section 4(2) of the Securities Act of 1933, as amended,  for
an exemption from  registration  of these shares and no underwriter  was used in
this transaction.

In  February,  August,  September  and  December  2005,  the  Company  issued an
aggregate 23,615 shares of restricted,  unregistered  common stock in payment of
approximately  $44,124 in accrued dividends payable on the Company's outstanding
Series B Preferred  Stock for the quarters  ended  December 31, 2004,  March 31,
2005, June 30, 2005, September 30, 2005 and December 31, 2005, respectively. The
Company relied upon Section 4(2) of the Securities Act of 1933, as amended,  for
an exemption from  registration  of these shares and no underwriter  was used in
this transaction.

In August,  November  and December  2005,  respectfully,  the Company  issued an
aggregate 37,500 shares of restricted,  unregistered common stock to an existing
shareholder as payment of various fees and costs  associated with the funding of
approximately  $875,000  short-term  working  capital loans to the Company.  The
Company relied upon Section 4(2) of the Securities Act of 1933, as amended,  for
an exemption from  registration  of these shares and no underwriter  was used in
this transaction.

Calendar 2006 Transactions

Jn  February   2006,  the  Company   issued   approximately   41,666  shares  of
unregistered,  restricted common stock to Paul Goebel, the Company's Director of
Domestic Sales, as an employee bonus.  These shares were valued at approximately
$17,500,  which  approximated  the market value of the shares on the transaction
date.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.


                                       16




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued

Note I - Common Stock Transactions

Calendar 2006 Transactions - continued

In February 2006, the Company issued approximately 226,065 shares of restricted,
unregistered  common  stock,  valued at  approximately  $18,325,  to an existing
shareholder as for payment of accrued  interest  associated  with  approximately
$875,000  short-term  working capital loans to the Company and  reimbursement of
direct public  relation  expenses.  The Company  relied upon Section 4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this  transaction.  As the per share value
of this  transaction  was  substantially  less  than  the  "fair  value"  of the
Company's  common stock,  per the closing price of the Company's common stock on
the transaction date, the Company  recognized  "compensation  expense related to
the  issuance  of  common  stock at less  than  "fair  value"  in the  amount of
approximately $70,080 on this transaction.

In May 2006,  the Company  issued  approximately  266,511  shares of restricted,
unregistered  common  stock,  valued at  approximately  $21,054,  to an existing
shareholder as for payment of accrued  interest  associated  with  approximately
$975,000  short-term  working capital loans to the Company and  reimbursement of
direct public  relation  expenses.  The Company  relied upon Section 4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this  transaction.  As the per share value
of this  transaction  was  substantially  less  than  the  "fair  value"  of the
Company's  common stock,  per the closing price of the Company's common stock on
the transaction date, the Company  recognized  "compensation  expense related to
the  issuance  of  common  stock at less  than  "fair  value"  in the  amount of
approximately $69,293 on this transaction.


Note J - Rental Commitments

The Company  leases its  corporate  office and  manufacturing  facility from its
controlling stockholder under a long- term operating lease agreement.  The lease
requires a monthly payment of approximately  $5,735,  including applicable sales
taxes.  The Company is responsible for all utilities and  maintenance  expenses.
The  lease  expires  on  December  1,  2009  and  contains  a clause  that  upon
expiration,  the Company and the controlling  shareholder  shall renegotiate the
annual rental amount.

The  Company's  subsidiary,  IPE,  leases it's  manufacturing  facility  from an
unrelated third-party under a long-term operating lease agreement. This lease is
for a period of five (5) years and requires graduated monthly payments, changing
on the lease anniversary date, ranging from approximately $1,751 to $1,914, plus
the applicable  sales taxes.  The Company is  responsible  for all utilities and
maintenance expenses.  The lease expires on February 28, 2007 and may be renewed
for an additional five (5) year term at a rental rate of  approximately  $1,971,
plus applicable sales taxes for the first renewal year and 3.0% increase on each
succeeding   anniversary   date.   Total  rent  expense  under  this  lease  was
approximately  $20,752 and  $16,622,  respectively,  for each of the years ended
December 31, 2004 and 2003.

In May  2004,  the  Company  entered  into a  long-term  lease  agreement  for a
warehouse  facility  adjacent to the Company's  primary office and manufacturing
facility.  This lease is for a period of two (2) years and requires  payments of
approximately  $6,206 per month for the first 12 months and approximately $6,393
for  the  second  12  months,  plus  applicable  sales  taxes.  The  Company  is
responsible  for all utilities and maintenance  expenses.  This lease expires on
May 31, 2006.  Further,  the Company is  responsible  for any  incremental  real
estate  taxes and property  insurance  in excess of the amounts  incurred by the
landlord for the calendar year immediately preceding the execution of the lease.




                                       17




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note J - Rental Commitments - Continued

Future minimum rental payments on the above leases are as follows:

                    Year ended
                    December 31,         Amount

                    2006               $ 117,244
                    2007                  72,643
                    2008                  68,815
                    2007                  68,815
                                       ---------
                    Totals             $ 327,517
                                       =========

For the respective years ended December 31, 2005 and 2004, the Company paid an
aggregate of $158,947 and $131,804 in rent under these three lease agreements.


Note M - Income Taxes

The components of income tax (benefit) expense for the six month periods ended
June 30, 2006 and 2005, respectively, are as follows:

                               Six months        Six months
                                  ended             ended
                                June 30,          June 30,
                                  2006            2005
                               -----------------------------
       Federal:
         Current                $     -           $    -
         Deferred                     -                -
                                -------           ------
                                      -                -
                                -------           ------
       State:
         Current                      -                -
         Deferred                     -                -
                                -------           ------
                                      -                -
                                -------           ------
         Total                  $     -           $    -
                                =======           ======

As of December 31, 2005,  the Company has a net operating loss  carryforward  of
approximately  $12,000,000 to offset future taxable  income.  Subject to current
regulations, components of this carryforward began to expire in 2005. The amount
and  availability  of the net  operating  loss  carryforwards  may be subject to
limitations set forth by the Internal  Revenue Code.  Factors such as the number
of shares ultimately issued within a three year look- back period; whether there
is a deemed more than 50 percent change in control; the applicable long-term tax
exempt bond rate;  continuity of historical  business;  and subsequent income of
the  Company  all  enter  into  the  annual   computation  of  allowable  annual
utilization of the carryforwards.















                (Remainder of this page left blank intentionally)




                                       18




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note M - Income Taxes - continued

The Company's income tax expense  (benefit) for the six month periods ended June
30, 2006 and 2005, respectively,  differed from the statutory federal rate of 34
percent as follows:

                                                          Six months  Six months
                                                             ended       ended
                                                           June 30,    June 30,
                                                             2006      2005
                                                          ----------------------

Statutory rate applied to loss before income taxes        $ (426,700) $(683,000)
Increase (decrease) in income taxes resulting from:
     State income taxes                                            -          -
     Other, including reserve for deferred tax asset         426,700    683,000
                                                          ----------  ---------

       Income tax expense                                 $        -  $       -
                                                          ==========  =========

Temporary differences, consisting primarily of the net operating loss
carryforward and statutory differences in the depreciable lives for property and
equipment, between the financial statement carrying amounts and tax bases of
assets and liabilities give rise to deferred tax assets and liabilities as of
December 31, 2005 and 2004, respectively:

                                                    Year ended     Year ended
                                                   December 31,   December 31,
                                                       2005            2004
                                                   -----------------------------
     Deferred tax assets - long-term
       Net operating loss carryforwards            $ 4,080,000      $ 2,669,000
     Deferred tax liabilities - long-term
       Statutory depreciation differences             (525,000)        (690,000)
                                                   -----------      -----------
                                                     3,555,000        1,979,000
     Less valuation allowance                       (3,555,000)      (1,979,000)
                                                   -----------      -----------

       Net Deferred Tax Asset                      $         -      $         -
                                                   ===========      ===========

During the years ended December 31, 2005 and 2004,  respectively,  the valuation
allowance increased (decreased) by approximately $1,576,000 and $(671,000).


Note N - Selected Financial Data (Unaudited)

The following is a summary of the quarterly  results of operations for the years
ended December 31, 2005 and 2004, respectively.



                                Quarter ended   Quarter ended   Quarter ended   Quarter ended   Year ended
                                  March 31,       June 30,      September 30,   December 31,    December 31,
                                                                                 
Calendar 2006
   Revenues - net               $     682,861   $     622,435
   Gross profit                 $    (442,994)  $     (20,703)
   Net earnings after
     provision for
     income taxes               $    (833,192)  $    (421,668)
   Basic and fully diluted
     earnings per share         $       (0.20)  $       (0.09)
   Weighted average
     number of shares
     issued and outstanding         4,270,491       4,797,286



                                       19




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note N - Selected Financial Data (Unaudited) - Continued



                                Quarter ended   Quarter ended   Quarter ended   Quarter ended   Year ended
                                  March 31,       June 30,      September 30,   December 31,    December 31,
                                                                                 
Calendar 2005
   Revenues - net               $   1,170,317   $     684,693   $    378,326    $   1,010,297   $  3,243,633
   Gross profit                 $    (366,263)  $    (676,300)  $   (757,023)   $     451,009   $ (1,348,577)
   Net earnings after
     provision for
     income taxes               $    (786,044)  $  (1,155,474)  $ (1,118,089)   $  (2,882,062)  $ (5,941,669)
   Basic and fully diluted
     earnings per share         $       (0.21)  $       (0.32)  $      (0.29)   $       (0.70)  $      (1.52)
   Weighted average
     number of shares
     issued and outstanding         3,742,585       3,557,402      3,812,069        4,126,366      3,907,499

Calendar 2004
   Revenues - net               $     281,507   $     568,785   $    861,988    $   1,535,088   $  3,247,368
   Gross profit                 $    (423,626)  $    (676,300)  $    377,181    $    (650,553)  $ (1,373,298)
   Net earnings after
     provision for
     income taxes               $  (1,188,358)  $  (1,155,307)  $      9,552    $    (983,960)  $ (3,318,073)
   Basic and fully diluted
     earnings per share         $       (0.35)  $       (0.32)  $       0.00    $       (0.26)  $      (0.92)
   Weighted average
     number of shares
     issued and outstanding         3,388,458       3,557,402      3,683,671        3,730,807      3,590,725




















                (Remainder of this page left blank intentionally)








                                       20




Item 2 - Management's Discussion and Analysis or Plan of Operation

Caution Regarding Forward-Looking Information

Certain statements contained in this Registration  Statement including,  without
limitation, statements containing the words "believes", "anticipates", "expects"
and  words  of  similar  import,  constitute  forward-looking  statements.  Such
forward-looking  statements  involve known and unknown risks,  uncertainties and
other factors that may cause the actual results,  performance or achievements of
the Company,  or industry  results,  to be materially  different from any future
results,   performance   or   achievements   expressed   or   implied   by  such
forward-looking statements.

Such factors include, among others, the following:  international,  national and
local general economic and market conditions:  demographic  changes; the ability
of the Company to sustain,  manage or  forecast  its growth;  the ability of the
Company to successfully make and integrate acquisitions;  raw material costs and
availability;  new product  development and  introduction;  existing  government
regulations  and  changes  in,  or  the  failure  to  comply  with,   government
regulations;  adverse publicity;  competition; the loss of significant customers
or suppliers;  fluctuations  and  difficulty in forecasting  operating  results;
changes in business strategy or development  plans;  business  disruptions;  the
ability  to attract  and  retain  qualified  personnel;  the  ability to protect
technology; and other factors referenced in this and previous filings.

Given these  uncertainties,  readers of this Quarterly Report on Form 10-QSB and
investors in our equity  securities are cautioned not to place undue reliance on
such forward-looking  statements. The Company disclaims any obligation to update
any such factors or to publicly  announce the result of any  revisions to any of
the  forward-looking  statements  contained  herein to reflect  future events or
developments.

General

American Ammunition,  Inc. is a holding company with two operating subsidiaries:
F&F Equipment, Inc. and Industrial Plating Enterprise Co.

F&F Equipment,  Inc. (F&F) was incorporated on October 4, 1983 under the laws of
the State of  Florida.  F&F was  formed to engage  principally  in the  "import,
export, retail & wholesale of firearms equipment, ammunition & other devices and
for the purpose of transacting any and/or all lawful business." F&F conducts its
business operations under the assumed name of "American Ammunition."

In June  2002,  American  Ammunition,  Inc.  formed a wholly  owned  subsidiary,
Industrial  Plating  Enterprise Co. (IPE),  which started production on June 14,
2002.  IPE  is a  fully  licensed  and  approved  electrochemical  metallization
facility with  significant  capacity for  processing  our line of projectiles as
well as other products and services while employing  environmentally sound water
conservation and proven waste treatment techniques.

Results of Operations

Six months ended June 30, 2006 compared with the six months ended June 30, 2005.

During the six months ended June 30, 2006, we experienced aggregate net revenues
of approximately  $1,305,000  ($622,000 in the current quarter),  as compared to
approximately  $1,855,000  during the first six  months of  Calendar  2005.  The
decline in sales was attributable to our curtailing of production during January
2006 to improve the  operating  efficiency  of our  manufacturing  equipment and
better automate select machines so we can rely upon lower labor  requirements in
future periods.

In 2004, the Company  initiated a direct  solicitation  program for it's "dealer
direct"  sales  program.  This  endeavor  has received a very  positive  initial
response from the qualified  retail resellers of the Company's  product.  We are
realizing that the existence of previously  announced  contracts with various U.
S. Governmental  agencies and orders from foreign  governments are becoming more
erratic in their order placements.  Accordingly,  management is realizing that a
consistent  demand  from the U. S.  retail  segment  will be our best  source of
consistent sales.  Further,  we have identified  certain production issues which
has inhibited the full  realization of existing  product  demands and management
believes  that the  necessary  steps are being  taken to remedy  any  production
deficiencies.

We  experienced  costs of goods  sold of  approximately  $1,769,000  for the six
months ended June 30, 2006 as compared to approximately $2,885,000 for the first
six months of Calendar 2005. Through June 30, 2006, and

                                       21




subsequent  thereto,  we continue to experience negative trends with relation to
our calculated  standard  production  costs for material and labor due to excess
labor capacity due to anticipated  governmental orders which did not materialize
as management  was led to believe from the various U. S.  Governmental  agencies
contracting  officers.  Management  remains of the opinion  that the  production
labor  force is stable and able to  maintain a constant  standard  of quality in
future periods. We experience variable costs in the area of material consumption
and direct labor.  In the second quarter of 2006,  management took drastic steps
to reduce excess labor capacity through the elimination of the 2nd shift,  which
was never able to reach full  utilization.  This action is not  expected to have
any  adverse  impact on our  ability to meet our  existing  and  future  product
demands.

For the six month  periods ended June 30, 2006 and 2005, we generated a negative
gross  profit  of  approximately  $(464,000),  or  (35,52%),  and  approximately
$(1,030,000), or (55.53%).

We experienced  nominal research and development  expenses of approximately $-0-
and $1,600, respectively, during the respective six month periods ended June 30,
2006 and 2005.

During the six  months of  Calendar  2006 and 2005,  we  expended  approximately
$74,000 and $112,000,  respectively,  in  advertising  and  marketing  expenses,
principally  in developing  and promoting our retail dealer direct  program.  We
anticipate  to continue our  marketing  efforts in this area in future  periods;
however,  the  volume  and  frequency  of  our  expenditures  may  fluctuate  as
management allocates available capital to these efforts.

Other general and administrative expenses increased nominally from approximately
$595,000  for the six months  ended June 30, 2006 as  compared to  approximately
$663,000 for the six months ended June 30,  2006.  Management  is of the opinion
that these costs are  relatively  stable and should not  experience  significant
increases except for inflationary  pressures caused  principally by increases in
energy  costs which are  affecting  all  businesses  in all sectors of the U. S.
economy.

We recognized a net loss of approximately  $(1,256,000) and $(2,010,000) for the
respective  six month  periods  ended June 30, 2006 and 2005,  respectively,  or
$(0.28) and $(0.58) per share.  We call to the reader's  attention that the loss
per share calculation for the six months ended June 30, 2005 includes the effect
of our 1 for 20 reverse stock split on January 9, 2006.

Liquidity And Capital Resources

As of June 30, 2006, December 31, 2005 and June 30, 2005,  respectively,  we had
working capital of approximately  $(1,701,000),  $(885,000) and $(265,000).  Our
working  capital  position  continues to fluctuate  based on  collections on our
trade accounts  receivable and  investments  from the mandatory  exercise of our
outstanding warrant related to our convertible debenture.  We anticipate that we
have sufficient  inventory levels to support our order demand and have access to
raw material  suppliers  that will enable us to receive raw materials for future
periods. We also note that we have approximately  $1,075,000 in short-term notes
payable to existing shareholders which may or may not be renegotiated, repaid in
common stock of the Company or otherwise reclassified prior to their maturity on
December 31, 2006. This amount is a contributing  factor to our negative working
capital position at June 30, 2006 and December 31, 2005.

We have  used cash in  operating  activities  of  approximately  $(500,000)  and
$(797,000)  during  the  six  month  periods  ended  June  30,  2006  and  2005,
respectively.  Due to  our  history  of  operating  losses,  our  resources  for
additional working capital are becoming more scarce. Additionally,  LaJolla Cove
Investors,  the holder of our  mandatorily  convertible  debenture  and  related
warrant,  is in default on their agreement to provide us with additional working
capital.  On March 1, 2006,  the Company issued a Private  Placement  Memorandum
offering up to 200,000 shares of 8% Convertible  Preferred  Stock at an offering
price  of $5.00  per  share  on a "best  efforts"  basis  through  an  unrelated
placement  agent.  As of June 30, 2006,  the Company had sole 50,000  shares for
gross  proceeds  of $250,000 in a single  transaction  pursuant to this  Private
Placement Memorandum.  Management continues to undertake all prudent measures to
assure that the Company can be self-supporting.

We anticipate that our liquidity position will continue to improve as management
is of the opinion that, with the current changes to our production capacity, the
Company will be in a position to better  support all existing  orders and accept
existing and future inquiries.

During  the six  months  ended June 30,  2006 and 2005,  respectively,  we added
approximately $31,000 and $98,000 in new equipment. Any equipment to be added in
future periods is fully dependent upon the Company's cash

                                       22




position, the availability of either new equity or debt capital and the ultimate
realization of communicated future product sales demand.  However, we may not be
able to obtain additional funding or, that such funding,  if available,  will be
obtained on terms favorable to or affordable by us.

Convertible Debenture

The Company  entered into a  Securities  Purchase  Agreement  with La Jolla Cove
Investors,  Inc. ("La Jolla") on October 4, 2002 for the sale of (I) $250,000 in
convertible  debentures and (ii) warrants to buy 30,000,000 shares of our common
stock.  On March 13, 2003 and May 6, 2003,  La Jolla  advanced an  aggregate  of
$350,000 to our company which such funding was  allocated  towards the principal
balance of our convertible debentures.

As of June 30, 2006, the  outstanding  balance on the  convertible  debenture is
approximately $226,365 and we have approximately 2,263,650 warrants outstanding.
A recap of the debenture activity is as follows:

                                 Debenture         Warrant
                                (in dollars)      (in shares)
                                ------------      -----------

           Initial amount       $    600,000        6,000,000
          2003 redemptions          (208,635)      (2,086,350)
          2004 redemptions          (125,000)      (1,250,000)
          2005 redemptions           (40,000)        (400,000)
                               -------------       -----------

          Balances outstanding
          at June 30, 2006     $     226,365        2,263,650
                               =============       ==========

The  debentures  bear  interest at 8%,  mature on June 31 [sic],  2007,  and are
convertible  into the  Company's  common  stock,  at the  selling  stockholder's
option.  The  convertible  debentures  are  convertible  into the  number of the
Company's shares of common stock equal to the principal amount of the debentures
being  converted  multiplied  by 11,  less the product of the  conversion  price
multiplied by 10 times the dollar amount of the debenture.  The conversion price
for the  convertible  debentures  is the lesser of (I) $1.00 or (ii) seventy six
percent of the average of the five lowest volume weighted  average prices during
the twenty (20) trading days prior to the conversion.  Accordingly,  there is in
fact no limit on the number of shares into which the debenture may be converted.
However,  in the event that our market  price is less than $0.30 per share,  the
Company  will have the option to prepay the  debenture  at 125% rather than have
the debenture  converted.  In addition,  the selling stockholder is obligated to
exercise the warrant  concurrently with the submission of a conversion notice by
the selling  stockholder.  As of June 30, 2006, the warrant is exercisable  into
2,263,650 shares of common stock at an exercise price of $1.00 per share.

In December 2004, we entered into an addendum to the  convertible  debenture and
warrant whereby the Company agreed to the following:

     *    the discount multiplier was reduced from eighty percent to seventy six
          percent;
     *    within five  business  days after this  registration  statement  being
          declared  effective,  La  Jolla is  required  to  submit  a  debenture
          conversion  in the  amount of  $10,000  and every  ten  business  days
          thereafter La Jolla shall submit three additional debenture conversion
          in the amount of $10,000 each;
     *    within five  business  days after this  registration  statement  being
          declared effective, La Jolla shall wire $400,000 to us as a prepayment
          towards the exercise of its warrant; and
     *    immediately  following  the  sale of all  shares  held by La  Jolla in
          connection with the debenture  conversions in the aggregate  amount of
          $40,000,  La Jolla shall wire  $275,000 to us as a prepayment  towards
          the exercise of its warrant and shall submit a debenture conversion in
          the amount of $6,250 on the first business day of each month until the
          debenture is no longer outstanding.

In May 2005, we entered into an additional addendum to the convertible debenture
and warrant whereby the Company agreed to the following:

     *    The Company shall deposit 4,000,000 unregistered shares in the name of
          LaJolla with the  Company's  Escrow Agent and,  upon  confirmation  of
          receipt,  LaJolla will wire the Company  $150,000 as an advance on the
          $400,000  amount that LaJolla was  obligated  to fund  pursuant to the
          December 2004 Addendum.  In the event that the Company's  Registration
          Statement  was not  declared  effective  within nine (9) months of the
          date of this Addendum, the 4,000,000 shares in escrow will be released
          to LaJolla and sold by LaJolla pursuant to

                                       23




          Rule 144. If LaJolla sells these shares for net sales proceeds of more
          than $150,000 (without  interest accruing on this amount),  the excess
          over $150,000 will be refunded to the Company.
     *    The  maturity  date  of the  convertible  debenture  and  warrant  was
          extended to June 31,  [sic],  2007.  * All other terms and  conditions
          remain in full force and effect.

LaJolla has contractually  agreed to restrict its ability to convert or exercise
its  warrants  and  receive  shares of our common  stock such that the number of
shares of common stock held by them and their  affiliates  after such conversion
or exercise does exceed 4.9% of the then issued and outstanding shares of common
stock.

Due to the  contractually  agreed  mandatory  conversion of this Debenture,  the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

As the warrant is  non-detachable  from the Debenture and requires  simultaneous
exercise upon  conversion of the Debenture,  no value was assigned to the issued
warrant.  Upon exercise of the warrant,  the Company will record the issuance of
the  underlying  shares as a new  issuance  of common  stock on the date of each
respective exercise.

On various dates through  December 31, 2003,  the  Debenture  Holder  elected to
convert an aggregate $208,635, through 24 separate transactions,  in outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 4,561,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 2,086,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $2,086,350.

On various  dates between  January 1, 2004 and December 31, 2004,  the Debenture
Holder   elected  to  convert  an   aggregate   $125,000,   through  6  separate
transactions,  in outstanding  Debenture principal into registered common stock.
This election  caused the Company to issue  4,150,000  shares of common stock to
the  Debenture  Holder.  Additionally,  pursuant  to  the  contract  terms,  the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase  1,250,000  shares of the Company's  common stock for gross proceeds of
$1,250,000.  As of December  31, 2004,  an aggregate of 1,000,000  shares of the
Company's  common  stock have been  issued by the  Company and are being held in
escrow by the Company's  counsel  pending receipt of the final $175,000 from the
Debenture Holder. As of June 30, 2006, this amount remains unpaid.

On various dates between June 28, 2005 and August 10, 2005, the Debenture Holder
elected to convert an aggregate  $40,000,  through 4 separate  transactions,  in
outstanding  Debenture  principal into  registered  common stock.  This election
caused the Company to issue  5,872,048  shares of common stock to the  Debenture
Holder.  Additionally,  pursuant to the contract  terms,  the  Debenture  Holder
concurrently  exercised a portion of the outstanding Warrant to purchase 400,000
shares of the Company's common stock for gross proceeds of $400,000.

LaJolla is in default on their contractual  agreements to redeem the outstanding
warrant(s) and convert the outstanding debenture as of June 30, 2006.


Item 3 - Controls and Procedures

(a)  Evaluation of Disclosure Controls and Procedures

     Under  the  supervision  and  with  the  participation  of our  management,
     including our principal  executive officer and principal financial officer,
     we conducted an evaluation of our disclosure  controls and  procedures,  as
     such term is defined under Rule 13a-15(e)  promulgated under the Securities
     Exchange Act of 1934, as amended (Exchange Act), as of June 30, 2006. Based
     on this evaluation, our principal executive officer and principal financial
     officer concluded that our disclosure controls and procedures are effective
     in alerting them on a timely basis to material  information relating to our
     Company required to be included in our reports filed or submitted under the
     Exchange Act.


                                       24




(b)  Changes in Internal Controls

     There were no significant changes (including corrective actions with regard
     to  significant  deficiencies  or  material  weaknesses)  in  our  internal
     controls over financial  reporting that occurred  during the second quarter
     of Calendar 2006 that has materially  affected,  or is reasonably likely to
     materially affect, our internal control over financial reporting.



                          Part II - Other Information


Item 1 - Legal Proceedings

None


Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

On March 31 and  June  30,  2006,  respectively,  the  holders  of the  Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340  shares  (9,170 shares per  conversion)  of Series B Preferred  Stock for
415,706 shares of restricted, unregistered common stock.

In May 2006,  the Company  issued  approximately  266,511  shares of restricted,
unregistered  common  stock,  valued at  approximately  $21,054,  to an existing
shareholder as for payment of accrued  interest  associated  with  approximately
$975,000  short-term  working capital loans to the Company and  reimbursement of
direct public  relation  expenses.  The Company  relied upon Section 4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this  transaction.  As the per share value
of this  transaction  was  substantially  less  than  the  "fair  value"  of the
Company's  common stock,  per the closing price of the Company's common stock on
the transaction date, the Company  recognized  "compensation  expense related to
the  issuance  of  common  stock at less  than  "fair  value"  in the  amount of
approximately $69,293 on this transaction

Series E 8% Convertible Preferred Stock

On March 1, 2006, the Company issued a Private Placement  Memorandum offering up
to 200,000  shares of 8%  Convertible  Preferred  Stock at an offering  price of
$5.00 per share on a "best efforts" basis through an unrelated placement agent.

The Series E 8% Convertible Preferred Stock provides for cumulative dividends at
the rate of 8% per  year,  payable  quarterly,  50% in cash and 50% in shares or
100% in cash at the Company's  election.  In the event the Company elects to pay
such dividends in shares of the Company's  Common Stock, the number of shares to
be issued shall be based on the average of the closing  prices of the  Company's
Common Stock, as reported on the NASDAQ Over the Counter Bulletin Board (or such
other  market on which the  Company's  Common  Stock is then  traded) for the 10
consecutive trading days preceding the record date for each such dividend,  with
such record date being the 14th day preceding the end of each calendar quarter.

Each share of Series E Convertible  Preferred  Stock shall be  convertible  into
shares of the Company's Common Stock at any time after March 1, 2007. The number
of  shares to be issued  on a  conversion  shall be based on 80% of the  average
closing price of the Common Stock of the Company;  as reported on the NASDAQ OTC
Bulletin Board (or such other market on which such stock is traded) for ten (!0)
consecutive  trading days preceding the date the Company received notice of such
conversion.  Subject  to  certain  restrictions,  the  Series  E 8%  Convertible
Preferred Stock shall automatically  convert into shares of the Company's Common
Stock upon any of the  following  events:  (I) the sale by the Company of all or
substantially  all of  its  assets;  (ii)  the  consummation  of a  merger  or a
consolidation  in which the  Company is not the  survivor;  or (iii) the sale or
exchange of all or substantially all of the outstanding  shares of the Company's
common  stock  (including  by way of  merger,  consolidation,  or other  similar
action).

In the event of the liquidation,  dissolution or winding up of the Company,  the
holders  of  Series E  Convertible  Preferred  Stock  shall  have a  liquidation
preference  over  holders of common  stock and shares  junior to the Series E 8%
Convertible Preferred Stock equal to $5.50 per share. Additionally,  the Company
shall not impose or allow any additional  liens on it's existing fixed assets in
excess of $1,000,000; provided that at such

                                       25




time as total gross proceeds from the offering equal or exceed  $2,000,000,  the
Company shall satisfy such existing liens on its existing fixed assets and shall
not impose or allow any  additional  liens on its existing  fixed assets  unless
subordinated  to the interest of the Series E 8%  Convertible  Preferred  Stock,
with such  preference  on the fixed assets  equal to the fixed asset  value,  as
determined in accordance with the United States  Generally  Accepted  Accounting
Principles  ("GAAP"),  of 150%  of the  stated  value  of the  aggregate  of the
outstanding  shares of Series E  Convertible  Preferred  Stock  except for fixed
assets of the  Company  that were  otherwise  purchased  pursuant  to a security
interest.

The Series E 8% Convertible  Preferred Stock shall be redeemable,  at the option
of the  Company,  for  cash in the  amount  of  $5.50  per  share  of  Series  E
Convertible  Preferred  Stock or for  shares of the  Company's  Common  Stock in
accordance with the Conversion  Rate, at any time after March 1, 2007, or in the
event the closing sale price of the Company's  Common Stock,  as reported on the
NASDAQ  Over the  Counter  Bulletin  Board  (or such  other  market on which the
Company's Common Stock is then traded),  is greater than or equal to $7.00 after
March 1, 2007 for any consecutive  five trading days. In addition,  the Series E
8% Convertible Preferred Stock shall be redeemable, at the option of the holder,
at any time for shares of the  Company's  Common  Stock in  accordance  with the
Conversion  Rate.  At any time after March 1, 2007, at the option of the holder,
the Series E 8% Convertible  Preferred Stock shall be redeemable for cash in the
amount of $5.10 per share of Series E Convertible  Preferred Stock or for shares
of the Company's Common Stock in accordance with the Conversion Rate. After such
date, if redemption is for cash,  shares will be redeemed at the rate of 1/10 of
such  aggregate  shares per  quarterly  period for any 10  consecutive  quarters
commencing  after  March 1, 2007.  Any  redemption  by either the Company or the
holder shall be subject to 15 days written notice.

The  Company  warrants  and  agrees  that if,  at any  time  within  the  period
commencing  on the date of the final closing of the Offering and expiring on the
5 th  anniversary  of the date thereof,  the Company  should file a registration
statement with the SEC under the Securities Act (other than in connection with a
merger or other  business  combination  transaction or pursuant to Form S-8), it
will give written  notice at least 30 calendar  days prior to the filing of each
such  registration  statement  to the  holders  of the  Series E 8%  Convertible
Preferred  Stock and the holders of the shares of the Common  Stock  issued upon
the  conversion or  redemption  of the shares of Series E Convertible  Preferred
Stock,  or their permitted  assigns  (Holders) of its intention to do so. If the
Holders  notify the Company  within 30 calendar  days after  receipt of any such
notice of its or their  desire to include any such shares of Common Stock issued
or issuable upon the  conversion  or  redemption of the Series E 8%  Convertible
Preferred Stock in such proposed registration  statement,  the Company shall use
its "best efforts" to have any such shares of Common Stock is issued or issuable
upon the conversion or redemption of the Series E 8% Convertible Preferred Stock
registered under such registration statement. Notwithstanding the foregoing, the
Company  shall  have the right at any time  after it shall  have  given  written
notice  (irrespective  of whether a written  request for  inclusion  of any such
securities  shall  have  been  made)  to elect  not to file  any  such  proposed
registration  statement,  or to withdraw  the same after the filing but prior to
the effective date thereof. If the managing  underwriter of an offering to which
the above  "piggyback  registration  rights" apply,  in good faith and for valid
business  reasons,  objects to such rights,  such objection  shall preclude such
inclusion. All expenses incurred by the Company in registration of the shares of
Common Stock issued or issuable upon the  conversion or redemption of The Series
E 8% Convertible Preferred Stock, including with out limitation all registration
and filing fees, listing fees, printing expenses,  fees and disbursements of all
independent  accounts, or counsel for the Company and the expense of any special
audits  incident  to or required by any such  registration  and the  expenses of
complying with the securities or blue sky laws of any jurisdiction shall be paid
by the Company.

The Company has agreed to pay the Placement Agent a cash commission equal to 10%
of the aggregate Purchase Price of the shares of Series E Convertible  Preferred
Stock sold by the Placement  Agent in the Offering  (Placement  Agent Fee).  The
Company shall also pay the Placement Agent reasonable  expenses  associated with
the Offering,  which expenses shall not exceed $50,000 (Expense  Allowance).  In
addition,  the Company shall issue to the Placement  Agent 500 warrants for each
$50,000 of Series E Convertible  Preferred  Stock sold by the Placement Agent in
the Offering  (Placement Agent Warrants),  each warrant  entitling the holder to
purchase 1 share of the Company's Common Stock at an exercise price of $0.90 per
share exercisable at any time for a period of 3 years from date of issuance.

Upon completion of the Maximum  Offering,  the Company will receive net proceeds
of  approximately  $900,000.00.  The Company intends to use the net proceeds for
potential  acquisitions,   working  capital,   general  corporate  purposes  and
repayment of outstanding debt.

                                       26




The  Company  and the  Placement  Agent shall have  discretion  to increase  the
Maximum Offering to $2,000,000.00, without notice to investors..

As of June 30, 2006, the Company has sold 50,000 shares in a single  transaction
under  this  Private  Placement  Memorandum  and has  received  the gross  sales
proceeds of $250,000  and has accrued a payable to the  Placement  Agent for the
10% (or $25,000) fee due on this  transaction.  The Company used the $250,000 in
proceeds to support it's  operations  during the 2nd quarter of Calendar 2006 as
shown on the accompanying statement of cash flows.


Item 3 - Defaults on Senior Securities

None


Item 4 - Submission of Matters to a Vote of Security Holders

None


Item 5 - Other Information

None


Item 6 - Exhibits

   Exhibits

31.1    Certification pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1    Certification pursuant to Section 906 of Sarbanes-Oxley Act of 2002.

----------------




                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                            American Ammunition, Inc.

Dated: August 16, 2006             /s/ Andres F. Fernandez
       ---------------          ------------------------------------
                                                 Andres F. Fernandez
                                  President, Chief Executive Officer
                                Chief Financial Officer and Director


                                       27